跳至主要内容
临床试验/NCT01462747
NCT01462747已完成2 期

An Open Prospective Study Evaluating the Efficacy and Safety of a Medical Device,KULIST, for the Treatment of Chronic, Non-complicated Perianal Fistulas

Nordic Drugs AB4 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2011年12月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
28
试验地点
4
主要终点
Clinical evaluation of fistula healing, change from baseline

研究概览

简要总结

The aim of this study is to evaluate the effects of rectally administered activated carbon (medical device KULIST) in chronic, uncomplicated, perianal fistulas.

详细描述

Patients with chronic uncomplicated perianal fistulas located below levator ani will be treated twice daily with KULIST for 8 weeks. The efficacy will be evaluated by means of an overall clinical evaluation of fistula closure, as well as by anal ultrasonography.

Also changes in Patient Assessment of Symptoms and Impact on Daily Function will be evaluated. Safety will be evaluated by standard adverse event /adverse device effects reporting.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with perianal fistulas diagnosed by clinical examination and evaluated as "not healed/open"
  • Fistula classified as intersphincteric and transsphincteric according to Parks´classification (Parks 1976)
  • Superficial fistula involving a part of the external sphincter muscle
  • Age: ≥18 years and ≤ 75 years
  • Informed consent and/or Letter of Authority (as applicable) obtained

排除标准

  • Inflammatory Bowel Disease (IBD)
  • Rectovaginal fistulas
  • Rectourethral fistulas
  • Rectovesical fistulas
  • Extra-sphincteric and supra-sphincteric fistula according to Parks´classification
  • Complicated fistulas (eg. horse shoe fistulas) as evaluated by the investigator.
  • Any surgical treatment for perianal fistulas
  • Colorectal and/or anal malignancy
  • Other malignancy requiring active treatment
  • Subcutaneous fistulas not involving any part of the external sphincter
  • Other diseases which as per the investigator's opinion should be contraindicated
  • Subjects who are not able to complete study procedures as per the investigator's opinion

结局指标

主要结局

Clinical evaluation of fistula healing, change from baseline

时间窗: week 8 and 24

Fistula assessed as healed/not healed

次要结局

  • Anal ultrasonography, change from baseline(week 8 and 24)
  • Patient assessment of Symptoms and Impact on Daily Function, change from baseline(week 8 and 24)
  • Safety, change from baseline(week 2, 8, 24)

研究者

发起方
Nordic Drugs AB
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验